| Normatec Industries Lp | |
| 480 Pleasant St, Ste A200, Watertown, Massachusetts 02472 | |
| (800) 335-0960 |
| Name | Normatec Industries Lp |
|---|---|
| Organization Name | Normatec Industries, Lp |
| Location | 480 Pleasant St, Ste A200, Watertown, Massachusetts 02472 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (800) 335-0960 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Genentech, Inc., a wholly-owned member of the Roche Group, today announced results from two Phase III studies of Lucentis (ranibizumab injection) in macular edema due to retinal vein occlusion (RVO), which showed, on average, patients given either of two doses of Lucentis had a clinically and statistically significant improvement in vision as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity (BCVA) at six months compared to patients receiving sham injections.
Most traditional cancer therapies target either the tumor cells themselves or indiscriminately kill any rapidly dividing cell.
The engineering of specific virus-targeting receptors onto a patient's own immune cells is now being explored by scientists from Duke-NUS Medical School (Duke-NUS), as a potential therapy for controlling infectious diseases, including the COVID-19-causing virus, SARS-CoV-2.
The cerebellum is a region of the brain that plays an important role in motor control. The Purkinje cells, a class of neurons located in this region, are a major site of information integration that regulate changes in neural connections caused by varying factors such as behavior, environment, and emotions. Thus Purkinje cells provide an ideal location for studying the mechanisms necessary for cerebellum dependent motor learning.
› Verified 9 days ago
| NPI Number | 1801956891 |
| Organization Name | NORMATEC, INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 600 Grant St, Suite 660, Pittsburgh, PA 15219 |
| Phone Number | 800-335-0960 |
News Archive
Genentech, Inc., a wholly-owned member of the Roche Group, today announced results from two Phase III studies of Lucentis (ranibizumab injection) in macular edema due to retinal vein occlusion (RVO), which showed, on average, patients given either of two doses of Lucentis had a clinically and statistically significant improvement in vision as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity (BCVA) at six months compared to patients receiving sham injections.
Most traditional cancer therapies target either the tumor cells themselves or indiscriminately kill any rapidly dividing cell.
The engineering of specific virus-targeting receptors onto a patient's own immune cells is now being explored by scientists from Duke-NUS Medical School (Duke-NUS), as a potential therapy for controlling infectious diseases, including the COVID-19-causing virus, SARS-CoV-2.
The cerebellum is a region of the brain that plays an important role in motor control. The Purkinje cells, a class of neurons located in this region, are a major site of information integration that regulate changes in neural connections caused by varying factors such as behavior, environment, and emotions. Thus Purkinje cells provide an ideal location for studying the mechanisms necessary for cerebellum dependent motor learning.
› Verified 9 days ago
News Archive
Genentech, Inc., a wholly-owned member of the Roche Group, today announced results from two Phase III studies of Lucentis (ranibizumab injection) in macular edema due to retinal vein occlusion (RVO), which showed, on average, patients given either of two doses of Lucentis had a clinically and statistically significant improvement in vision as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity (BCVA) at six months compared to patients receiving sham injections.
Most traditional cancer therapies target either the tumor cells themselves or indiscriminately kill any rapidly dividing cell.
The engineering of specific virus-targeting receptors onto a patient's own immune cells is now being explored by scientists from Duke-NUS Medical School (Duke-NUS), as a potential therapy for controlling infectious diseases, including the COVID-19-causing virus, SARS-CoV-2.
The cerebellum is a region of the brain that plays an important role in motor control. The Purkinje cells, a class of neurons located in this region, are a major site of information integration that regulate changes in neural connections caused by varying factors such as behavior, environment, and emotions. Thus Purkinje cells provide an ideal location for studying the mechanisms necessary for cerebellum dependent motor learning.
› Verified 9 days ago
Cvs Pharmacy # 01012 Type: Medicare Supplier Location: 27-43 Main Street, Watertown, Massachusetts 02472 Phone: (617) 926-6662 | |
Cvs Pharmacy #01018 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 189 Watertown St, Watertown, Massachusetts 02472 Phone: (617) 332-2861 | |
Cvs Pharmacy #10601 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 655 Mount Auburn Street, Watertown, Massachusetts 02472 Phone: (617) 744-0842 | |
Cvs Pharmacy #16774 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 550 Arsenal St, Watertown, Massachusetts 02472 Phone: (617) 924-5987 | |
Normatec Industries Lp Type: Durable Medical Equipment & Medical Supplies Supplier Location: 480 Pleasant St, Watertown, Massachusetts 02472 Phone: (800) 335-0960 |